Prospective Multicentre Study Assessing the Feasibility of Enhanced Recovery After Sleeve Gastrectomy for Obesity

N/AUnknownNCT02042365

University Hospital, Clermont-Ferrand150 enrolled

Overview

The primary purpose of the study is to test the feasibility of a protocol of enhanced recovery after surgery for reducing the total length of hospital stay in a large scale setting

This observational study evaluates the feasibility of ERAS pathway in six French departments of surgery located at Clermont-Ferrand, Bordeaux, Montpellier, Amiens, Strasbourg and Aurillac.

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Obesity

Interventions

ERAS (Enhanced recovery after surgery)PROCEDURE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Obese patients undergoing a sleeve gastrectomy Patients having signed the informed consent Patients over 18 year old ASA 1-3 Obesity with indication for surgery according the guidelines of the French High Authority for Health BMI \< 50 kg/m2 No contra-indication for general anesthésia Exclusion Criteria: contra-indication for general anesthésia Age under 18 years ASA 4 BMI \> 50 kg/m2 Patients having other serious comorbidities: cardiac, pulmonary, diabete, immunodepression, coagulopathy ou anticoagulant therapy Pregnancy Patients living alone

Locations (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, France

Outcomes

Primary Outcomes

Duration of hospital stay

Posoperative day when the patients satisfies the criteria of discharge

Time frame: at day 1

Central Contacts

Patrick LACARIN

CONTACT

04 73 75 11 95 placarin@chu-clermontferrand.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.